These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 208764)

  • 1. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL; Becker FF
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract]   [Full Text] [Related]  

  • 2. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
    Castro CE; Felkner IC; Yang SP
    Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
    Schut HA; Thorgeirsson SS
    Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
    [No Abstract]   [Full Text] [Related]  

  • 4. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation.
    Stout DL; Baptist JN; Matney TS; Shaw CR
    Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of 2-aminofluorene and 2-acetylaminofluorene to mutagens by rat hepatocyte nuclei.
    Stout DL; Becker FF
    Cancer Res; 1979 Apr; 39(4):1168-73. PubMed ID: 421200
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution of alpha-fetoprotein- and albumin-containing cells in the livers of Fischer rats fed four cycles of N-2-fluorenylacetamide.
    Sell S
    Cancer Res; 1978 Sep; 38(9):3107-13. PubMed ID: 79445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Binding of 2-acetylaminofluorene-9-14C with rat liver nucleic acids during malignization and in primary hepatomas].
    Ivanov SD; Dzhioev FK
    Biull Eksp Biol Med; 1977 Mar; 83(3):332-4. PubMed ID: 192387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations.
    Kurelec B; Krca S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cholesterol biosynthesis in rat liver after the administration of N-2-fluorenylacetamide.
    Calandra S; Guariento D; Rivasi F
    Lab Invest; 1973 Jun; 28(6):723-7. PubMed ID: 4351645
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse.
    Sakai S; Reinhold CE; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1978 Jul; 38(7):2058-67. PubMed ID: 26463
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
    Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
    Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
    Jacobs MM; Matney TS; Griffin AC
    Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
    McGregor D
    Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive RNA-DNA hybridization of nuclear and microsomal RNA during diethylnitrosamine hepatocarcinogenesis.
    Garrett CT; Katz C; Moore RE; Pitot HC
    Cancer Res; 1973 Jul; 33(7):1662-9. PubMed ID: 4352795
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytochrome P-450 in hyperplastic liver nodules during hepatocarcinogenesis with N-2-fluorenylacetamide in rats.
    Okita K; Noda K; Fukumoto Y; Takemoto T
    Gan; 1976 Dec; 67(6):899-902. PubMed ID: 191326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of monooxygenases in rhesus monkeys by 3-methylcholanthrene: metabolism and mutagenic activation of N-2-acetylaminofluorene and benzo(a)pyrene.
    Thorgeirsson SS; Sakai S; Adamson RH
    J Natl Cancer Inst; 1978 Feb; 60(2):365-9. PubMed ID: 413928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrophotometric analysis of cytochromes in rat liver during carcinogenesis.
    Oyanagui Y; Sato N; Hagihara B
    Cancer Res; 1974 Mar; 34(3):458-62. PubMed ID: 4359875
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of aminothiols in 2-acetylaminofluorene-treated rats. III. Metabolic activation of aromatic amines.
    De Flora S; Camoirano A; Bennicelli C; Orunesu M; Cesarone CF
    In Vivo; 1987; 1(2):101-7. PubMed ID: 2979769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.